By identifying upregulation of the entire Cu transport cascade (CTR1, ATOX1, ATP7A, and LOX), the data from this study demonstrate that Cu and Cu-dependent enzymes may play an important role in HPH and the Cu transporters may be good targets to develop therapeutic approaches for pulmonary hypertension. This evidence concerns the gene SLC31A1 and pulmonary arterial hypertension.